Melioidosis

Melioidosis was first recognized in northeastern Brazil in 2003. Confirmation of additional cases from the 2003 cluster in Ceara more recent cases in other districts, environmental isolation of Burkholderia pseudomallei, molecular confirmation and typing results, and positive serosurveillance specimens indicate that melioidosis is more widespread in northeastern Brazil than previously thought.

**********

Melioidosis is a fatal bacterial infection found in many parts of the tropical belt, particularly in Southeast Asia and northern Australia. Sporadic cases of the disease have been reported previously in Central and South America (1). In 2003 septicemic melioidosis was diagnosed for the first time in northeastern Brazil by culture of the causal agent, Burkholderia pseudomallei from a 10-year-old boy (2). That case is believed to be the first culture-confirmed case of melioidosis in Brazil and was part of a small cluster of cases (hereafter termed Brazil outbreak 1). At first, evidence that >1 case of melioidosis had occurred was circumstantial. The diagnosis relied entirely on the phenotypic features of a blood culture isolate from the 10-year-old boy. A more detailed, multidisciplinary investigation obtained further evidence for the case cluster and clarified its likely relationship to infection in the surrounding population.

The Study

Outbreak 1 comprised 4 previously healthy children from the Municipality of Tejussuoca; the children were admitted to the hospital with clinical features of systemic infection over the course of 10 days (February 28-March 7, 2003) (Table 1; online Appendix Figure, available from http://www.cdc.gov/ncidod/EID/vol11no09/05-0493_app.htm). Three of the children died because of multiple organ systems failure. Patient 1 died shortly after admission to a local hospital, before any diagnostic microbiology tests could be arranged. Gram-negative bacilli were isolated by blood culture from 2 children, patient 2 and patient 3. For patient 2, the isolate did not survive preliminary laboratory analysis, but findings at autopsy were consistent with melioidosis (3). In patient 3, the isolate was presumptively identified as B. pseudomallei. Bacterial identification and susceptibility results came too late to guide the treatment of patient 3, who also died, but did lead to changes in antimicrobial drug therapy of patient 4, who was admitted to the hospital later than the other 3 patients, survived, and remains healthy. In her case, melioidosis was demonstrated by laboratory evidence of late seroconversion, detected by indirect hemagglutination assay. Preliminary epidemiologic investigations indicated that the children were probably infected when diving into an irrigation reservoir that filled shortly after the onset of the summer rains.

Environmental studies conducted shortly after the case cluster occurred (and then repeated with improved methods at a later date) did not isolate B. pseudomallei from this location or other nearby sites. A detailed review of surveillance methods was undertaken, and external advice was sought shortly before the ensuing rainy season. The presumptive B. pseudomallei isolate from patient 3 was sent to a reference laboratory for independent confirmation and molecular typing. A case definition was established for prospective epidemiologic surveillance, and seroepidemiologic studies began. External advice was sought for environmental isolation methods.

The first clinical isolate (outbreak 1, patient 3, the 10-year-old boy) was confirmed as B. pseudomallei by phenotypic and molecular methods, according to a validated discovery pathway (4). In brief, polymerase chain reaction (PCR)--based identification, gas-liquid chromatography of fatty acid methyl esters, and an agglutinating monoclonal antibody were used to confirm the isolate presumptively identified as B. pseudomallei.

Just over 1 year later, in 2004, several suspected cases of septicemic melioidosis occurred in another location in the State of Cearfi (outbreak 2). The B. pseudomallei isolate from 1 such patient and 2 B. pseudomallei isolates from soil and water samples in the corresponding environmental study were sent for confirmation and molecular typing, as before. The patient was from the Municipality of Banabuiu, [approximately equal to] 400 km from the location of outbreak 1. She used to wash clothing while sitting in a nearby river. She first complained of a perineal abscess, which persisted for 2 weeks before she was admitted to the hospital with septicemia. B. pseudomallei was isolated by blood culture after she died. The B. pseudomallei environmental isolates were from river water taken near where she washed clothes and from soil from the compacted earth floor under the tub she bathed in at home.

EcoR1 ribotyping showed that the B. pseudomallei isolate from patient 3 in the 2003 outbreak 1 was similar to the Western Australian outbreak strain (Table 2, online Appendix Figure). EcoR1 ribotyping discriminated between 3 of the 4 Brazil B. pseudomallei isolates (Brazil outbreak 1, patient 3: ribotype 1; unrelated later case in second district: ribotype 6; and 2 environmental isolates from second district: ribotypes 1 and 4). However, ribotyping was not as discriminating as DNA macrorestriction typing (pulsed-field gel electrophoresis, PFGE), which showed that the Brazil and Western Australian outbreak isolates were distinct strains (Brazil outbreak, patient 3: PFGE type 2, Western Australian outbreak strain: PFGE type 1). Autopsy results from patient 2 in the original case cluster were similar to those of the culture-positive third case-patient and were consistent with melioidosis (3). The 1 survivor of the case cluster (Brazil outbreak 1, patient 4) seroconverted (titer = 1:160) from an undetectable indirect hemagglutination assay (IHA) titer around the time of her infection. One parent was borderline positive by IHA (titer of 1:40), and one was negative by IHA (<10).

Of the 36 persons from both districts tested by IHA for serologic evidence of exposure to B. pseudomallei, 14 had titers [greater than or equal to]1:40; 7 had a titer of [greater than or equal to]1:160; and 2 had titers of 1:5,120. No significant associations occurred between seropositivity and district, or seropositivity and age. However, seropositivity and sex were significantly associated (Fisher exact test, p = 0.0159, relative risk = 0.320, 95% confidence interval [CI] = 0.12-0.83); 10 of 16 female patients had titers [greater than or equal to]40, the threshold titer, compared to 4 of 20 male patients. This apparent association between female sex and seropositivity is the reverse of the association expected from experience in Southeast Asia.

Conclusions

At the time of writing, sporadic human infection has been reported sporadically from other locations in northeastern Brazil, consistent with an emerging infectious disease. Prospective case surveillance, improved laboratory diagnosis, and targeted environmental bacteriologic testing will help clarify the epidemiology of melioidosis in this region. Why this disease has appeared in Brazil remains obscure, although our preliminary molecular typing results indicate a possible link with Australian and Southeast Asian infections through a putative common progenitor strain. Veterinary investigation may help identify a possible means of introduction of the disease, since the goats that feature in subsistence fanning in Ceara may have been imported from parts of the Caribbean where caprine melioidosis is known to occur (5). An alternative hypothesis is that B. pseudomallei was introduced through rice cultivation. An environmental search for B. pseudomallei (then Pseudomonas pseudomallei) was conducted shortly after melioidosis was first reported in South and Central America (6): a large number of water samples from rice fields near Sao Paulo were cultured. No P. pseudomallei was found, which led to the conclusion that the temperature and moisture of the environment did not favor the microorganism. More recently, B. pseudomallei has been presumptively identified in the root soil of sugar cane in the Sao Paulo region (7). Rice is grown in parts of Ceara where melioidosis cases have been identified and is an important crop in other parts of the country. Further epidemiologic and environmental studies are needed to determine the extent of the environmental hazard and the risk it represents for the human population and their livestock in northern Brazil. Finally, the terrain in Ceara has many similarities to northern Australia, where the summer rains are known to coincide with most septicemic melioidosis cases (8). In some parts of the Caribbean, sporadic melioidosis cases appear to be a harbinger of more common disease when flooding or other climatic determinants prevail (9,10). The surveillance methods recently introduced in Ceara may therefore help predict future melioidosis events. Data on melioidosis serology results in an epidemic setting are limited. The seroepidemiology survey conducted after the Western Australian melioidosis outbreak relied on access to previous serum samples from the same community, fortuitously collected for other purposes before the outbreak (11). Results from a serologic survey based on single samples from each study participant, as in Ceara, will necessarily have much wider CI. The investigation into the Western Australian outbreak identified persons who seroconverted without clinical evidence of B. pseudomallei infection. Carefully planned prospective seroepidemiologic studies in northeastern Brazil will clarify the importance of these preliminary observations. Establishing the true prevalence of melioidosis in northeastern Brazil will help ascertain the threshold for serodiagnosis and the clinical relevance of borderline results.

In the absence of any obvious anthropogenic changes known to increase melioidosis risk, the unusual weather systems operating in early 2003 appear to be the most likely explanation for the apparent temporal and positional clustering of cases. The diversity of molecular types of B. pseudomallei and the seroprevalence of B. pseudomallei antibody--positive persons are more consistent with an endemic disease that has gone undetected for several years than a recent, point-source incursion. Further epidemiologic studies will need to address whether the apparent emergence of melioidosis in northeastern Brazil is due primarily to improved ascertainment, the regional impact of climate change, changes in land use, or a combination of these factors.

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the Centers for Disease Control and Prevention or the institutions with which the authors are affiliated.

Acknowledgments

We are grateful to our colleagues at the Health Secretariat of the State of Ceara, The Federal University of Ceara, and the Division of Microbiology and Infectious Diseases, PathWest, Perth, Western Australia, for their support for this work, in particular J. Frutuoso, J.L.N. Rodrigues, and D.W. Smith, respectively.

Dr Rolim is a specialist in infectious diseases with the State Secretary of Health and the Sao Jose Hospital in Fortaleza, Ceara, northeastern Brazil. In 2004, she completed studies for a postgraduate qualification in public health from the Federal University of Ceara with a dissertation on the first outbreak of melioidosis in Brazil.

References

(1.) Dance DA. Melioidosis: the tip of the iceberg? Clin Microbiol Rev. 1991 ;4:5-60.

(2.) Miralles IS, Maciel Mdo C, Angelo MR, Gondini MM, Frota LH, dos Reis CM, et al. Burkholderia pseudomallei: a case report of a human infection in Ceara, Brazil. Rev Inst Med Trop Sao Paulo. 2004;46:51-4.

(3.) Braga MD, Almeida PR. First description of an autopsied case of melioidosis in Ceara State. Rev Soc Bras Med Trop. 2005;38:58-60.

(4.) Inglis TJJ, Merritt A, Chidlow G, Aravena-Roman M, Harnett G. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J Clin Microbiol. 2005;43:2201-6.

(5.) Sutmoller P, Kraneveld Fc, Van Der Schaaf A. Melioidosis (pseudomalleus) in sheep, goats, and pigs on Aruba (Netherland Antilles). J Am Vet Med Assoc. 1957;130:415-7.

(6.) Conference proceedings. Rhizosphere 2004. 2004 Sep 12-17. Munich, Germany. Munich: National Research Centre; 2004. p. 58.

(7.) Pestana de Castro AF, Campedelli O, Giorgi W, Santa Rosa CA. Consideracoes sobre a melioidose e o seu agente causal: Pseudomonas pseudomallei. Rev Inst Med Yrop Sao Paulo. 1973;15:43-9.

(8.) Currie BJ, Jacups SE Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis. 2003;9:1538-42.

(9.) Dorman SE, Gill V J, Gallin JI, Holland SM. Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin Infect Dis. 1998;26:889-94.

(10.) Christenson B, Fuxench Z, Morales JA, Suarez-Villamil RA, Souchet LM. Severe community-acquired pneumonia and sepsis caused by Burkholderia pseudomallei associated with flooding in Puerto Rico. Bol Asoc Med P R. 2003;95:17-20.

(11.) Inglis TJ, Garrow SC, Adams C, Henderson M, Mayo M, Currie BJ. Acute melioidosis outbreak in Western Australia. Epidemiol Infect. 1999;123:437-43.

Dionne Bezerra Rolim, * Dina Cortez Feitosa Lima Vilar, ([dagger]) Anastacio Queiroz Sousa, * Iracema Sampaio Miralles, ([double dagger]) Diana Carmen Almeida de Oliveira, ([dagger]) Gerry Harnett, ([section]) Lyn O'Reilly, ([section]) Kay Howard, ([section]) Ian Sampson ([section]) and Timothy J.J. Inglis ([section])

* Hospital Sao Jose, Ceara, Brazil; ([dagger]) Secretaria da Saude do Estado do Ceara, Ceara, Brazil; ([double dagger]) Central Laboratory of Public Health for the State of Ceara, Ceara, Brazil; and ([section]) Western Australian Centre for Pathology and Medical Research, Nedlands, Perth, Western Australia, Australia

Address for correspondence: Timothy J.J. Inglis, Division of Microbiology and Infectious Diseases, Western Australian Centre for Pathology and Medical Research (PathWest), Hospital Ave, QEII Medical Centre, Nedlands, Perth, WA 6909, Australia; fax: 618-9381-7139; email: tim.inglis@health.wa.gov.au

COPYRIGHT 2005 U.S. National Center for Infectious Diseases
COPYRIGHT 2005 Gale Group